Avidity Biosciences Inc. (RNA) Social Stream
AVIDITY BIOSCIENCES INC (RNA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering RNA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $50 | $36 | $45.333 | $8.1 | 459.67% |
| 2021-12-10 | 4 | $53 | $50 | $51 | $8.1 | 529.63% |
| 2022-05-10 | 3 | $50 | $50 | $50 | $8.1 | 517.28% |
| 2022-08-10 | 5 | $50 | $29 | $36 | $8.1 | 344.44% |
| 2022-09-28 | 5 | $50 | $27.001 | $35.25 | $8.1 | 335.19% |
| 2022-11-09 | 5 | $50 | $27 | $35.5 | $8.1 | 338.27% |
| 2022-12-14 | 6 | $71 | $27 | $45.75 | $8.1 | 464.81% |
| 2023-03-01 | 6 | $71 | $27 | $47.6 | $8.1 | 487.65% |
| 2023-03-30 | 6 | $71 | $27 | $44.8 | $8.1 | 453.09% |
| 2023-04-28 | 6 | $71 | $26 | $42.8 | $8.1 | 428.4% |
| 2023-05-10 | 7 | $71 | $26 | $42.8 | $8.1 | 428.4% |
| 2023-05-11 | 7 | $71 | $20 | $39 | $8.1 | 381.48% |
| 2023-08-08 | 7 | $71 | $20 | $39 | $8.1 | 381.48% |
| 2023-08-10 | 7 | $71 | $20 | $37.833 | $8.1 | 367.07% |
| 2023-11-09 | 6 | $71 | $23 | $41.4 | $8.1 | 411.11% |
| 2023-11-28 | 6 | $71 | $18 | $40.4 | $8.1 | 398.77% |
The Trend in the Analyst Price Target
RNA's average price target has moved down $3.93 over the prior 33 months.
RNA reports an average of 310.82% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-14 | 6 | 71 | 27 | 45.75 | 17.05 | 168.33% |
| 2022-12-14 | 5 | 71 | 27 | 45.75 | 17.05 | 168.33% |
| 2023-08-08 | 7 | 71 | 20 | 39.00 | 8.93 | 336.73% |
| 2023-11-09 | 6 | 71 | 23 | 41.40 | 5.48 | 655.47% |
| 2023-11-09 | 6 | 71 | 18 | 40.40 | 5.48 | 637.23% |
RNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.17 | 5 | 1 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 29 months, RNA's average broker recommendation rating improved by 0.58.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RNA as an investment opportunity.
- AVIDITY BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 1835.61% of all US stocks.
- RNA has a lower variance in analysts' estimates than -1258.36% of all US stocks.
- In terms of how AVIDITY BIOSCIENCES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 459.14% of that group.
- In the context of stocks in the small market cap category, AVIDITY BIOSCIENCES INC's average analyst price target is greater than 1713.58% of them.
In the Pharmaceutical Products industry, GBIO, RPTX, and PNT are the three stocks most similar to AVIDITY BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is RNA a Buy, Hold or Sell? See the POWR Ratings now!